U.S. Oil and Gas Stock News

In late May 2026, Privia Health Group, Inc. signed a definitive agreement to enter the New Jersey market by partnering with the Neurology Group of Bergen County, a 25-clinician adult and pediatric neurology practice that will anchor Privia Medical Group, New Jersey and is expected to be on the Privia platform by year-end 2026. This partnership gives Privia a foothold in a new state while extending its interoperable technology and population health capabilities to community neurologists and...

AbbVie (ABBV) stock has been in focus after a series of recent drug approvals, including European clearance for Aquipta in acute migraine, an expanded EU label for Venclyxto in first-line CLL, and FDA approval of Decnupaz for BPDCN. See our latest analysis for AbbVie. Those approvals have arrived alongside firm share price momentum, with AbbVie’s 1 month share price return of 10.83% and 7 day share price return of 4.37% standing against a slightly weaker 90 day share price return and strong 5...

WEC Energy Group (WEC) drew investor attention after reporting first quarter 2026 earnings of $2.45 per share, which surpassed estimates, reaffirmed its 2026 outlook and underscored ongoing investment in natural gas and renewable projects. See our latest analysis for WEC Energy Group. The first quarter beat and reaffirmed outlook come after a mixed year for the stock, with the share price up 6.09% year to date but down over the past three months. The 5 year total shareholder return of 43.97%...

In May 2026, Icahn Enterprises L.P. reported first-quarter 2026 results showing revenues of US$2.20 billion, a GAAP net loss of US$459 million, and a US$201 million increase in Indicative Net Asset Value largely tied to gains in its CVI position. The Board also declared a quarterly distribution of US$0.50 per depositary unit, payable in cash or additional units, highlighting management’s continued emphasis on returning capital to unitholders despite reported losses. Next, we’ll consider how...

Why Verizon Communications (VZ) Is Back on Investors’ Radar Verizon Communications (VZ) has drawn fresh attention after recent share price moves, with the stock up 1.1% over the past day but down over the past week and month. For investors tracking longer stretches, Verizon shows a gain year to date and over the past year, set against a decline over the past 3 months. This creates a mixed backdrop for reassessing the telecom giant. See our latest analysis for Verizon Communications. With the...

In recent days, Provident Financial Services has benefited from a broader regional bank rally amid a stable, higher-for-longer interest rate backdrop that is supporting sector-wide net interest margins. Separately, Provident Bank’s appointment of Annamaria Vitelli as Executive Vice President, Chief Wealth Officer and President of Beacon Trust highlights a renewed push to grow its wealth management and fiduciary services franchise. We'll now examine how the sector-wide rate backdrop and...

EPR Properties recently presented at Nareit REITweek 2026 in New York, where President, CEO and Board Chair Gregory K. Silvers outlined the REIT’s focus on experiential real estate, including multiplex theaters. This update comes as domestic movie theaters are experiencing their strongest year since 2019, with significantly higher ticket sales supporting renewed interest in experiential assets. With theater ticket sales rebounding strongly, we’ll now assess how this demand backdrop may shape...

Granite Construction (GVA) has been active on multiple fronts this week, securing two construction contracts worth a combined US$60 million and closing a US$600 million senior notes offering that supplies additional funding capacity for upcoming work. See our latest analysis for Granite Construction. Those new contracts and the US$600 million senior notes sit against a strong backdrop, with the share price up 19.11% year to date and a 1 year total shareholder return of 54.54%, while the 5...

Event Overview and Recent Stock Moves West Pharmaceutical Services (WST) has drawn fresh attention after recent trading, with the stock closing at US$314.50. Short term performance has been mixed, with a 0.9% daily decline and a 2.6% slide over the past week. See our latest analysis for West Pharmaceutical Services. While the 1 day share price return is down 0.9% and the 7 day share price return is down 2.6%, the 90 day share price return of 27.9% and 1 year total shareholder return of 40.4%...

Ulta Beauty stock moves after recent performance shifts Ulta Beauty (ULTA) has drawn fresh investor attention after a period in which the stock declined around 13% over the past month and about 28% over the past 3 months. Those moves contrast with a roughly flat 1 year total return of about 0.3%. The 3 year and 5 year total returns, at about 10% and 38% respectively, highlight how timing has influenced shareholder outcomes. See our latest analysis for Ulta Beauty. At a share price of $467.07,...

In recent days, Morgan Stanley downgraded Chipotle Mexican Grill to Equal Weight and flagged that its sales drivers may be less compelling than some fast-food peers amid inflation, wage, and freight cost pressures. At the same time, Chipotle has continued pushing brand initiatives such as its “53 Years. 53 Real Ingredients” basketball-themed burrito giveaway, underscoring management’s focus on marketing and long-term expansion despite short-term caution from analysts. With the stock...

Recent performance context for Toro stock Toro (TTC) has drawn attention after the stock fell about 9% over the past month and about 12% over the past 3 months, even as its 1 year total return remains positive. See our latest analysis for Toro. With the share price at $87.21, the recent 1-month share price return of about 9% down and 3-month share price return of about 12% down contrast with a stronger 1-year total shareholder return of about 30%. This suggests momentum has faded even as...

Boeing and Riyadh Air recently announced that the new Saudi carrier’s first two 787 Dreamliners have been delivered to Riyadh, marking an early step toward a planned fleet of up to 72 aircraft serving more than 100 destinations by 2030. This delivery milestone underlines how Boeing’s widebody program is tied into Saudi Arabia’s broader aviation push to attract 150 million visitors and serve 330 million passengers annually by the end of the decade. Next, we’ll examine how the Riyadh Air 787...

Recent performance snapshot Micron Technology (MU) has drawn fresh attention after recent share price moves, with the stock down 13% over the past day and 11% over the past week, while remaining higher over the past month and the past 3 months. See our latest analysis for Micron Technology. The recent pullback comes after a powerful run, with the stock still showing a 174% year to date share price return and a very large 1 year total shareholder return. This suggests momentum is cooling...

If you are wondering whether DexCom at around US$72.86 is a bargain or a stock to be cautious about, the next step is to look closely at what that price might already be pricing in. The stock has risen 20.7% over the past month and is up 9.5% year to date, even though it is down 1.2% over the past week and has declined 15.9% over the last year and 41.4% over three years. Recent headlines around glucose monitoring, reimbursement policies and competition in medical devices help explain why...

Centrus Energy (LEU) has been under pressure after its first quarter 2026 results, as a higher full year revenue outlook and growing low enriched uranium backlog met softer earnings, missed revenue expectations, sector weakness, and valuation questions. See our latest analysis for Centrus Energy. The Q1 2026 report and sector weakness have gone hand in hand with sharp share price pressure. The stock is down 30.06% over 30 days and 40.63% year to date on a share price basis, even though the 5...

Recent share performance context Fastly (FSLY) has drawn attention after a sharp share price move, with the stock down about 43% over the past month and roughly 10% over the past 3 months, despite a strong year to date gain. See our latest analysis for Fastly. The recent 1 day share price decline of 9.24% and 1 month share price return of down 42.76% contrast with a stronger year to date share price return of 77.33% and a 1 year total shareholder return of 135.90%. This suggests that momentum...

Shift4 Payments (FOUR) is back on investors’ radar after Loman AI announced a partnership that plugs its restaurant voice platform directly into Shift4’s Dine POS system, tying call handling and order intake to payments technology. See our latest analysis for Shift4 Payments. Despite the Loman AI partnership highlighting product expansion, momentum in Shift4’s stock has been fading, with the share price at US$38.08 and the year to date share price return down 39.25%, while the 1 year total...

Some Microsoft Corporation ( NASDAQ:MSFT ) shareholders may be a little concerned to see that the Executive VP & CEO of...

Rockwell Medical, Inc. ( NASDAQ:RMTI ), might not be a large cap stock, but it saw significant share price movement...

It looks like Edgewell Personal Care Company ( NYSE:EPC ) is about to go ex-dividend in the next three days. The...

Q1 earnings miss and sharp stock reaction DXP Enterprises (DXPE) recently reported first quarter results with revenue and adjusted operating income below analyst estimates, even though sector peers generally cleared expectations. The stock has fallen 14.5% since the release. See our latest analysis for DXP Enterprises. That sharp post earnings drop comes after a strong run, with the stock still up 46.1% on a year to date share price basis and a very large 5 year total shareholder return of...

Flowers Foods (NYSE:FLO) reported that board member Thomas C. Chubb III has voluntarily resigned after six years of service. Chubb previously served as independent presiding director and chair of the Nominating/Corporate Governance Committee. The company stated that his resignation is due to external professional demands rather than disagreements with Flowers Foods. Flowers Foods, the packaged bakery company behind a range of fresh breads and snack products, now faces an adjustment in its...

Praxis Precision Medicines (PRAX) has moved into focus after reporting Phase 2/3 POWER1 data for vormatrigine in focal onset seizures, missing the primary endpoint while hitting a key secondary measure and pausing the follow on POWER2 trial. See our latest analysis for Praxis Precision Medicines. The vormatrigine setback has triggered a sharp pullback, with a 1 day share price return down 4.06% and a 7 day share price return down 27.42%. However, the 1 year total shareholder return is still...